Finance

Iambic prices its IPO, seeking to raise up to $160m

Scancell revs up for Nasdaq listing as cancer vaccine developer prepares phase III melanoma trial

S&P 500 Sector Outlook: Favor XLC And XLK, Underweight XLP With Uneven Earnings Leadership

Tokenization could unleash tens of billions of dollars in trapped capital, Nasdaq CEO says